EUVIMEDEUVIMED entdecken
Open Access

Inhibition of EREG/ErbB/ERK by Astragaloside IV reversed taxol-resistance of non-small cell lung cancer through attenuation of stemness via TGFβ and Hedgehog signal pathway

Wenhao Xiu, Yujia Zhang, Dongfang Tang, Sau Har Lee, Rui Zeng, Tingjie Ye, Hua Li, Yanlin Lu, Changtai Qin, Yuxi Yang, Xiaofeng Yan, Xiaoling Wang und 4 weitere

Cellular Oncology · 2024

DOI: 10.1007/s13402-024-00999-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, 2024. Verfasst von Wenhao Xiu und 15 weiteren Autor:innen. Beteiligte Einrichtung: School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Paclitaxel, Hedgehog Proteins, Lung Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NSFC grant, the budget research project of Shanghai University of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungPaclitaxelHedgehog ProteinsLung NeoplasmsDrug Resistance, NeoplasmTransforming Growth Factor betaSignal TransductionErbB ReceptorsTriterpenesMice, NudeEpiregulinHumansCell Line, TumorAnimalsNeoplastic Stem CellsSaponinsMiceMice, Inbred BALB CXenograft Model Antitumor AssaysMAP Kinase Signaling System

Stichwörter der Autor:innen

ASIVEREGNon-small cell lung cancerStemnessTaxol-resistance

Substanzen

PaclitaxelHedgehog ProteinsTransforming Growth Factor betaErbB ReceptorsTriterpenesEpiregulinSaponinsEREG protein, human

Autor:innen und Institutionen

  • School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
  • Department of Clinical Medicine, Suzhou Vocational Health College, Suzhou, Jiangsu, China.
  • Department of Thoracic Surgery, Huadong Hospital Affiliated to Fudan University, Shanghai, China.
  • School of Biosciences, Faculty of Health and Medical Sciences, Taylor's University, Subang Jaya, Selangor, Malaysia.
  • Department of Oncology and Institute of Traditional Chinese Medicine in Oncology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • School of Life Science and Technology, Tongji University, Shanghai, China.

Förderung

  • NSFC grant
  • the budget research project of Shanghai University of Traditional Chinese Medicine

Zitieren

APA

Xiu, W., Zhang, Y., Tang, D., Lee, S. H., Zeng, R., Ye, T., Li, H., Lu, Y., Qin, C., Yang, Y., Yan, X., Wang, X., Hu, X., Chu, M., Sun, Z., & Xu, W. (2024). Inhibition of EREG/ErbB/ERK by Astragaloside IV reversed taxol-resistance of non-small cell lung cancer through attenuation of stemness via TGFβ and Hedgehog signal pathway. Cellular Oncology. https://doi.org/10.1007/s13402-024-00999-7

Vancouver

Xiu W, Zhang Y, Tang D, Lee SH, Zeng R, Ye T, et al. Inhibition of EREG/ErbB/ERK by Astragaloside IV reversed taxol-resistance of non-small cell lung cancer through attenuation of stemness via TGFβ and Hedgehog signal pathway. Cellular Oncology. 2024. doi:10.1007/s13402-024-00999-7

BibTeX
@article{Xiu2024,
  author = {Xiu, Wenhao and Zhang, Yujia and Tang, Dongfang and Lee, Sau Har and Zeng, Rui and Ye, Tingjie and Li, Hua and Lu, Yanlin and Qin, Changtai and Yang, Yuxi and Yan, Xiaofeng and Wang, Xiaoling and Hu, Xudong and Chu, Maoquan and Sun, Zhumei and Xu, Wei},
  title = {Inhibition of EREG/ErbB/ERK by Astragaloside IV reversed taxol-resistance of non-small cell lung cancer through attenuation of stemness via TGFβ and Hedgehog signal pathway},
  journal = {Cellular Oncology},
  year = {2024},
  doi = {10.1007/s13402-024-00999-7}
}
Kostenlos starten →